| From : | sbelkania@moh.gov.ge |
| To : | David Sergeenko |
| Subject : | FW: Simplified Regimens and Primary Care/Harm Reduction |
| Received On : | 04.01.2018 07:11 |
| Attachments : |
FYI
საუკეთესო სურვილებით,
სოფო ბელქანია
ადამიანური რესურსების მართვისა და საერთაშორისო ურთიერთობების დეპარტამენტის უფროსი
საქართველოს შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო
აკ. წერეთლის გამზირი 144, თბილისი, საქართველო, 0159
მობ: +995 599 223232
From: David Sergeenko [mailto:dsergeenko@moh.gov.ge]
Sent: Thursday, December 14, 2017 2:36 PM
To: Sopo Belkania
Subject: FW: Simplified Regimens and Primary Care/Harm Reduction
From: "Averhoff, Francisco (CDC/OID/NCHHSTP)" <fma0@cdc.gov>
Date: Wednesday, December 13, 2017 10:38 PM
To: Davit Sergeenko <dsergeenko@moh.gov.ge>
Cc: "Skaggs, Beth (CDC/CGH/DGHP)" <bgs7@cdc.gov>, "Gamkrelidze, Amiran (CDC ncdc.ge)" <a.gamkrelidze@ncdc.ge>, "Nasrullah, Muazzam (CDC/OID/NCHHSTP)" <hij9@cdc.gov>
Subject: Simplified Regimens and Primary Care/Harm Reduction
Dear Dr. Sergeenko,
Thank you for hosting us in Georgia, it was great to see you and to move this important program forward. I think that great progress was made.
As discussed during the decentralization meeting, there are proposed implementation projects to begin to rollout simplified regimens and screening, care and treatment services in harm reduction and primary care settings. These concepts have been discussed, proposals developed and approved by the scientific committee. The approved proposals are attached. In order to implement these projects, the primary investigators need government (i.e. MOLHSA) approval. These projects are ready to be rolled out and will help inform the national rollout of simplified regimens and services in harm reduction and primary care services. Please confirm your approval of these projects and/or advise if you need any additional information.
Please note that these projects are intended to precede the national rollout, but do require MOLHSA approval. For the national rollout, these concepts will be further elaborated and will be presented to the scientific committee and we will discuss the results with you at that time.
Please let us know if you have any questions/comments or would like to speak.
Best, FA
Francisco Averhoff MD, MPH
CAPT US Public Health Service
Associate Director for Global Health
Division of Viral Hepatitis
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
1600 Clifton Road, MS G-37
Atlanta, GA 30333
phone: 404-718-8501
fax: 404-718-8588
e-mail: fma0@cdc.gov